Tata Fund Pours up to $10 Million into Apex Kidney Care

Tata Capital Healthcare Fund II (TCHF II), the healthcare-focused private equity fund under Tata Capital, has made an investment of up to $10 million in Apex Kidney Care (AKC), securing an undisclosed equity stake. AKC, the second-largest dialysis chain in India, plans to utilize this infusion of capital to broaden its dialysis services nationwide.

 

India grapples with an estimated 2 million patients in Stage-5 Chronic Kidney Disease (CKD), where kidney function falls below 15%. Each year, an additional 0.2 to 0.22 million CKD-5 patients emerge. Presently, approximately 21 million dialysis sessions occur annually in India, covering only about 11% of the nation's overall yearly demand. This glaring gap stems from a mix of issues related to accessibility, affordability, and adherence.

 

Dr. Jatin Kothari, Co-founder and Director at Apex Kidney Care, expressed, "This new collaboration affirms the worth of our business model and our vision to provide top-tier dialysis services. The combined expertise holds the promise of unveiling numerous new opportunities to advance the business, ultimately positively impacting the lives of thousands of kidney disease patients."

Related Blogs
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
blog-logo

Share Market

blog-logo

11 mins read . 08 Jul 2024

How to Withdraw SIP Amount?

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions